Yoav Amitai – CEO – Elsight's (ASX:ELS) Halo provides connectivity and delivers absolute connection confidence for drones and other unmanned systems.
Copyright 2023 – Finance News Network
Source: Finance News Network
02 Sep 2019 - Lithium Consolidated Limited (ASX:LI3) CEO, Shanthar Pathmanathan talks about the company's capital raising and focus on hard rock lithium and sale of its US lithium brine asset to Argosy Minerals.
Read More05 May 2022 - Torian Resources Limited (ASX:TNR) Executive Chairman Paul Summers and Senior Geologist Claudio Sheriff discuss the significance of the company's rare earths discovery.
Read More27 Oct 2022 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's recent deal with Japanese group Macnica and the launch of a new product.
Read More14 July 2023 - Shaw and Partners Chief Investment Officer Martin Crabb takes a look at the current economic situation and what it means for portfolios and investments going forward.
Read More23 Oct 2019 - Cashwerkz Limited (ASX:CWZ) Executive Director, Craig Swanger talks about the company's platform, the benefit it provides for both banks and investors, FY19 results and outlook.
Read More19 Apr 2022 - Novatti Group Limited (ASX:NOV) CEO and Managing Director Peter Cook discusses innovations in the payment space, strategy and outlook.
Read More08 Jun 2021 - MLC Asset Management Senior Economist Bob Cunneen discusses factors behind gains in the global economy and the Australian market over May.
Read More11 Apr 2022 - Trigg Mining Limited (ASX:TMG) CEO and Managing Director Keren Paterson discusses the global demand for potash, the difference between sulphate of potash and muriate of potash, and the company's flagship project at Lake Throssell in Western Australia.
Read More25 Nov 2020 - Melbana Energy (ASX:MAY) Executive Chairman Andrew Purcell provides an update on its portfolio with particular focus on its onshore Cuban project Block 9, the potential size of the field, drilling program and funding.
Read More25 Feb 2020 - Noxopharm Limited (ASX:NOX) Chief Medical Officer, Dr Gisela Mautner, talks about results from the company's LuPIN trial in prostate cancer, evaluating its lead product candidate, Veyonda, in combination with 177Lu-PSMA-617, a radiopharmaceutical therapy, in 56 patients with late-stage prostate cancer.
Read More
